Optiver Holding
NUVB icon

Optiver Holding’s Nuvation Bio NUVB Stock Holding History

Optiver Holding’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48K Sell
344
-144
-30% -$802 ﹤0.01% 1967
2025
Q4 		$4.37K Sell
488
-1,878
-79% -$11.6K ﹤0.01% 1470
2025
Q3 		$8.75K Buy
+2,366
New +$6.45K ﹤0.01% 1377

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Optiver Holding's NUVB Position: Q1 2026 in Review

Optiver Holding reduced its Nuvation Bio (NUVB) stake by 30% in Q1 2026, selling an estimated $802 and leaving 344 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1967.

Optiver Holding first reported a position in NUVB in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.75K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Optiver Holding held 344 shares of Nuvation Bio worth $1.48K as of Q1 2026.
  • Optiver Holding sold 144 Nuvation Bio shares in Q1 2026, an estimated $802.
  • Nuvation Bio made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1967 holding.
  • Optiver Holding first reported a position in Nuvation Bio in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Nuvation Bio position peaked at $8.75K in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.